Abstract
Kidney transplantation is a widely used method throughout the world for the treatment of end-stage renal disease. Following the pioneering work of Szeged Medical University Hospital and Miskolc District General Hospital, the first successful kidney transplantation in Hungary was performed at the Department of Transplantation and Surgery at Semmelweis Medical University on November 16, 1973. This patient is still alive with a functioning kidney graft after 21 years. We report herein our review of the global results of Hungarian kidney transplantation. Hungary is a medium-developed country with a population of over 10 million where the gross national product is about 4000 U.S. dollars per person per year. In Hungary there are 49 dialysis centers, 4 immunological laboratories, and 4 transplantation centers.
Similar content being viewed by others
References
Calne RY (1980) Transplantation surgery: Current status. Br J Surg 67:765–771
Diethelm AG, Deierhoi MH, Hudson SL (1995) Progress in renal transplantation. A single center study of 3359 patients over 25 years. Ann Surg 221:446–458
Ayob G, Terasaki PI (1981) Improved DR typing of cadaver donors by lymphocyte incubation. Tissue Antigens 18:58–62
Washburn WK, Shaffer D, Conway P (1995) A single-center experience with six-antigen-matched kidney transplants. Arch Surg 130(3):277–282
Persijn GG, Gabb BW, Leeuven A van (1978) The effect of matching for HLA-A, B and DR antigens on kidney graft survival in Eurotransplant. Lancet 1:494–495
Tiwari JL (1985) Review: Kidney transplantation and HILA. In: Terasaki PI (ed) Clinical kidney transplants 1985. UCLA Tissue Typing Laboratory. Los Angeles, pp 233–256
Perner F, Járay J, Alföldy F (1984) Experiences with ureteroureteral anastomosis in renal transplantation. Transplant Proc 16:1335–1336
Hilbrands LB, Hoitsma AJ, Koene RA (1995) The effect of immunosuppressive drugs on quality of life after renal transplantation. Transplantation 59:1263–1270
Tornatore KM, Biocevich DM, Reed K (1995) Methylprednisolone pharmacokinetics, cortisol response, and adverse effects in black and white renal transplant recipients. Transplantation 59:729–736
Borel JF (1982) The history of cyclosporine A and its significance. In: White DJG (ed) Cyclosporine A. Elsevier, Amsterdam, pp 5–17
Bennett WM, Burdmann EA, Andoh TF (1994) Nephrotoxicity of immunosuppressive drugs. Nephrol Dial Transplant. 9 [Suppl IV 4]:141–145
Opelz G (1985) Correlation of HLA matching with kidney graft survival in patients with or without cyclosporine treatment. Transplantation 40:140–143
Abouna GM, Al-Abdullah IH, Kelly-Sullivan D (1995) Randomised clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring Transplantation 59:1564–1568
Bock HA, Gallati H, Zurcher RM (1995) A randomized prospective trial of prophylactive immunosuppression with ATG-Fresenius versus OKT3 after renal transplantation. Transplantation 59:830–840
Anderson CB, Sicard GA, Etheredge EE (1979) Delayed renal function and long-term cadaver renal allograft survival. Transplant Proc 11:482
Kerman RH, Sullivan EK, Tejani A (1995) Impact of HLA matching, type of crossmatch, and immunosuppressive therapy on primary pediatric cadaver renal allograft survival. Transplant Proc 27:656–657
Petrie JJ, Rigby RJ, Hawley CM (1995) Effect of OKT3 in steroid-resistant renal transplant rejection. Transplantation 59:347–352
Bradley BA, Gilks WR, Gore SM (1986) Beneficial HLA matching in centers using cyclosporine A. In: Terasaki PI (ed) Clinical transplants. UCLA Tissue Typing Laboratory, Los Angeles, p 130
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Perner, F., Járay, J., Alföldy, F. et al. The results of 1009 kidney transplantations performed in Hungary. Surg Today 26, 561–567 (1996). https://doi.org/10.1007/BF00311568
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00311568